These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37791494)

  • 1. Examination of the relationship between symptom and performance validity measures across referral subtypes.
    Boress K; Gaasedelen O; Kim JH; Basso MR; Whiteside DM
    J Clin Exp Neuropsychol; 2024 Mar; 46(2):162-171. PubMed ID: 37791494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of MMPI-2-RF Symptom Validity Scales and Performance Validity Test Relationships in a Diverse Mixed Neuropsychiatric Setting.
    De Boer AB; Phillips MS; Barwegen KC; Obolsky MA; Rauch AA; Pesanti SD; Tse PKY; Ovsiew GP; Jennette KJ; Resch ZJ; Soble JR
    Psychol Inj Law; 2023; 16(1):61-72. PubMed ID: 36348958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance and symptom validity assessment in attention deficit/hyperactivity disorder: Base rates of invalidity, concordance, and relative impact on cognitive performance.
    Ovsiew GP; Cerny BM; Boer AB; Petry LG; Resch ZJ; Durkin NM; Soble JR
    Clin Neuropsychol; 2023 Oct; 37(7):1498-1515. PubMed ID: 36594201
    [No Abstract]   [Full Text] [Related]  

  • 4. Base Rates of Performance and Symptom Validity Test Failures in Active Duty and Veteran Samples Referred for Attention-Deficit/Hyperactivity Disorder Evaluation.
    Shura RD; Armistead-Jehle P
    Arch Clin Neuropsychol; 2024 May; 39(4):523-527. PubMed ID: 38073319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Performance Validity Measures in Predicting MMPI-2 Lie Scale Results.
    Richey LN; Doninger NA
    Clin Neuropsychol; 2020 Feb; 34(2):353-367. PubMed ID: 31340718
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical utility of the memory complaints inventory to detect invalid test performance.
    Armistead-Jehle P; Grills CE; Bieu RK; Kulas JF
    Clin Neuropsychol; 2016 May; 30(4):610-28. PubMed ID: 27117938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting coached neuropsychological dysfunction: a simulation experiment regarding mild traumatic brain injury.
    Lau L; Basso MR; Estevis E; Miller A; Whiteside DM; Combs D; Arentsen TJ
    Clin Neuropsychol; 2017 Nov; 31(8):1412-1431. PubMed ID: 28415909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobehavioral symptom validity in U.S. Department of Veterans Affairs (VA) mild traumatic brain injury evaluations.
    Ashendorf L
    J Clin Exp Neuropsychol; 2019 May; 41(4):432-441. PubMed ID: 30712457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Evaluation Board Involvement, Non-Credible Cognitive Testing, and Emotional Response Bias in Concussed Service Members.
    Mooney SR; Stafford J; Seats E
    Mil Med; 2018 Nov; 183(11-12):e546-e554. PubMed ID: 29590406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance validity and symptom validity tests: Are they measuring different constructs?
    Ord AS; Shura RD; Sansone AR; Martindale SL; Taber KH; Rowland JA
    Neuropsychology; 2021 Mar; 35(3):241-251. PubMed ID: 33829824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Performance and Symptom Validity Test Findings After Mild Traumatic Brain Injury.
    Donders J; Lefebre N; Goldsworthy R
    Arch Clin Neuropsychol; 2021 Apr; 36(3):394-402. PubMed ID: 31732733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratified performance on the Test of Memory Malingering (TOMM) is associated with differential responding on the Personality Assessment Inventory (PAI).
    Whiteside DM; Hunt I; Choate A; Caraher K; Basso MR
    J Clin Exp Neuropsychol; 2020 Mar; 42(2):131-141. PubMed ID: 31771455
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the MMPI-2-RF and PAI overreporting indicators in a civil forensic sample with emphasis on the Response Bias Scale (RBS) and the Cognitive Bias Scale (CBS).
    Tylicki JL; Rai JK; Arends P; Gervais RO; Ben-Porath YS
    Psychol Assess; 2021 Jan; 33(1):71-83. PubMed ID: 33090826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the sensitivity of the Personality Assessment Inventory symptom validity tests in detecting response bias in a mixed neuropsychological outpatient sample.
    Gaasedelen OJ; Whiteside DM; Basso M
    Clin Neuropsychol; 2017 Jul; 31(5):844-856. PubMed ID: 28391774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between Symptom Validity Test failure and scores on the MMPI-2-RF validity and substantive scales.
    Gervais RO; Wygant DB; Sellbom M; Ben-Porath YS
    J Pers Assess; 2011; 93(5):508-17. PubMed ID: 21859291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of assessing for validity of symptom report and performance in attention deficit/hyperactivity disorder (ADHD): Introduction to the special section on noncredible presentation in ADHD.
    Suhr JA; Berry DTR
    Psychol Assess; 2017 Dec; 29(12):1427-1428. PubMed ID: 29227123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rate of psychiatric disorders in veterans undergoing intensive EEG monitoring is associated with symptom and performance invalidity.
    Binder LM; Tadrous-Furnanz SK; Storzbach D; Larrabee GJ; Salinsky MC
    Clin Neuropsychol; 2022 Nov; 36(8):2120-2134. PubMed ID: 34632958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom and performance validity with veterans assessed for attention-deficit/hyperactivity disorder (ADHD).
    Shura RD; Denning JH; Miskey HM; Rowland JA
    Psychol Assess; 2017 Dec; 29(12):1458-1465. PubMed ID: 29227127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of validity testing in psychiatric assessment: evidence from a sample of multimorbid post-9/11 veterans.
    Kim S; Currao A; Brown E; Milberg WP; Fortier CB
    J Int Neuropsychol Soc; 2024 May; 30(4):410-419. PubMed ID: 38014547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom and performance validity in neuropsychological assessments of outpatients 15-30 years of age.
    Boe EW; Evald L
    Brain Inj; 2022 Dec; ():1-7. PubMed ID: 36527248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.